Distillate Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Distillate Capital Partners's AMGN Position: Q1 2026 in Review
Distillate Capital Partners sold out of Amgen (AMGN) in Q1 2026, closing a stake of 87,695 shares — an estimated $28.7M sold.
Distillate Capital Partners first reported a position in AMGN in Q4 2020 and held it in 17 quarters. The position peaked at $77.6M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Distillate Capital Partners reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- Distillate Capital Partners sold 87,695 Amgen shares in Q1 2026, an estimated $28.7M.
- Distillate Capital Partners first reported a position in Amgen in Q4 2020 and held it in 17 quarters.
- Distillate Capital Partners's Amgen position peaked at $77.6M in Q3 2024.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Distillate Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.